Cargando…

Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis

Malignant pleural mesothelioma (MPM) is a cancer associated with asbestos exposure and its diagnosis is challenging due to the moderate sensitivities of the available methods. In this regard, miR-103a-3p was considered to increase the sensitivity of established biomarkers to detect MPM. Its behavior...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Ramírez, Carmina, Gilbert Weber, Daniel, Aguilar-Madrid, Guadalupe, Brik, Alexander, Juárez-Pérez, Cuauhtémoc Arturo, Casjens, Swaantje, Raiko, Irina, Brüning, Thomas, Johnen, Georg, Cabello-López, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565669/
https://www.ncbi.nlm.nih.gov/pubmed/36240245
http://dx.doi.org/10.1371/journal.pone.0275936
_version_ 1784808947385892864
author Jiménez-Ramírez, Carmina
Gilbert Weber, Daniel
Aguilar-Madrid, Guadalupe
Brik, Alexander
Juárez-Pérez, Cuauhtémoc Arturo
Casjens, Swaantje
Raiko, Irina
Brüning, Thomas
Johnen, Georg
Cabello-López, Alejandro
author_facet Jiménez-Ramírez, Carmina
Gilbert Weber, Daniel
Aguilar-Madrid, Guadalupe
Brik, Alexander
Juárez-Pérez, Cuauhtémoc Arturo
Casjens, Swaantje
Raiko, Irina
Brüning, Thomas
Johnen, Georg
Cabello-López, Alejandro
author_sort Jiménez-Ramírez, Carmina
collection PubMed
description Malignant pleural mesothelioma (MPM) is a cancer associated with asbestos exposure and its diagnosis is challenging due to the moderate sensitivities of the available methods. In this regard, miR-103a-3p was considered to increase the sensitivity of established biomarkers to detect MPM. Its behavior and diagnostic value in the Mexican population has not been previously evaluated. In 108 confirmed MPM cases and 218 controls, almost all formerly exposed to asbestos, we quantified miR-103-3a-3p levels in leukocytes using quantitative Real-Time PCR, together with mesothelin and calretinin measured in plasma by ELISA. Sensitivity and specificity of miR-103-3a-3p alone and in combination with mesothelin and calretinin were determined. Bivariate analysis was performed using Mann-Whitney U test and Spearman correlation. Non-conditional logistic regression models were used to calculate the area under curve (AUC), sensitivity, and specificity for the combination of biomarkers. Mesothelin and calretinin levels were higher among cases, remaining as well among males and participants ≤60 years old (only mesothelin). Significant differences for miR-103a-3p were observed between male cases and controls, whereas significant differences between cases and controls for mesothelin and calretinin were observed in men and women. At 95.5% specificity the individual sensitivity of miR-103a-3p was 4.4% in men, whereas the sensitivity of mesothelin and calretinin was 72.2% and 80.9%, respectively. Positive correlations for miR-103a-3p were observed with age, environmental asbestos exposure, years with diabetes mellitus, and glucose levels, while negative correlations were observed with years of occupational asbestos exposure, creatinine, erythrocytes, direct bilirubin, and leukocytes. The addition of miR-103a-3p to mesothelin and calretinin did not increase the diagnostic performance for MPM diagnosis. However, miR-103a-3p levels were correlated with several characteristics in the Mexican population.
format Online
Article
Text
id pubmed-9565669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95656692022-10-15 Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis Jiménez-Ramírez, Carmina Gilbert Weber, Daniel Aguilar-Madrid, Guadalupe Brik, Alexander Juárez-Pérez, Cuauhtémoc Arturo Casjens, Swaantje Raiko, Irina Brüning, Thomas Johnen, Georg Cabello-López, Alejandro PLoS One Research Article Malignant pleural mesothelioma (MPM) is a cancer associated with asbestos exposure and its diagnosis is challenging due to the moderate sensitivities of the available methods. In this regard, miR-103a-3p was considered to increase the sensitivity of established biomarkers to detect MPM. Its behavior and diagnostic value in the Mexican population has not been previously evaluated. In 108 confirmed MPM cases and 218 controls, almost all formerly exposed to asbestos, we quantified miR-103-3a-3p levels in leukocytes using quantitative Real-Time PCR, together with mesothelin and calretinin measured in plasma by ELISA. Sensitivity and specificity of miR-103-3a-3p alone and in combination with mesothelin and calretinin were determined. Bivariate analysis was performed using Mann-Whitney U test and Spearman correlation. Non-conditional logistic regression models were used to calculate the area under curve (AUC), sensitivity, and specificity for the combination of biomarkers. Mesothelin and calretinin levels were higher among cases, remaining as well among males and participants ≤60 years old (only mesothelin). Significant differences for miR-103a-3p were observed between male cases and controls, whereas significant differences between cases and controls for mesothelin and calretinin were observed in men and women. At 95.5% specificity the individual sensitivity of miR-103a-3p was 4.4% in men, whereas the sensitivity of mesothelin and calretinin was 72.2% and 80.9%, respectively. Positive correlations for miR-103a-3p were observed with age, environmental asbestos exposure, years with diabetes mellitus, and glucose levels, while negative correlations were observed with years of occupational asbestos exposure, creatinine, erythrocytes, direct bilirubin, and leukocytes. The addition of miR-103a-3p to mesothelin and calretinin did not increase the diagnostic performance for MPM diagnosis. However, miR-103a-3p levels were correlated with several characteristics in the Mexican population. Public Library of Science 2022-10-14 /pmc/articles/PMC9565669/ /pubmed/36240245 http://dx.doi.org/10.1371/journal.pone.0275936 Text en © 2022 Jiménez-Ramírez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Jiménez-Ramírez, Carmina
Gilbert Weber, Daniel
Aguilar-Madrid, Guadalupe
Brik, Alexander
Juárez-Pérez, Cuauhtémoc Arturo
Casjens, Swaantje
Raiko, Irina
Brüning, Thomas
Johnen, Georg
Cabello-López, Alejandro
Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title_full Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title_fullStr Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title_full_unstemmed Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title_short Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
title_sort assessment of mir-103a-3p in leukocytes—no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565669/
https://www.ncbi.nlm.nih.gov/pubmed/36240245
http://dx.doi.org/10.1371/journal.pone.0275936
work_keys_str_mv AT jimenezramirezcarmina assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT gilbertweberdaniel assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT aguilarmadridguadalupe assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT brikalexander assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT juarezperezcuauhtemocarturo assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT casjensswaantje assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT raikoirina assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT bruningthomas assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT johnengeorg assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis
AT cabellolopezalejandro assessmentofmir103a3pinleukocytesnodiagnosticbenefitincombinationwiththebloodbasedbiomarkersmesothelinandcalretininformalignantpleuralmesotheliomadiagnosis